bioMérieux increases its holding in Hybiome from 54% to 67%
06 June, 2019 bioMérieux, a world leader in the field of in vitro diagnostics, today announced an increase of its shareholding in Suzhou Hybiome Biomedical Engineering Co. Ltd. This announcement follows the earlier announcement of the acquisition of a majority stake in this company in November 2018. Founded in 2009 and located in Suzhou (China), Hybiome is specialized... Read more